Non-myeloablative stem cell transplant using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome (MDS)

T. Saito, S. Seo, R. Tanosaki, Y. Takaue, S. Mineishi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Non-myeloablative conditioning regimens for allogeneic stem cell transplant have become popular recently. With non-myeloablative conditioning, regimen-related toxicities (RRT) are mild and engraftment of allogeneic graft can be achieved consistently. We performed non-myeloablative allogeneic peripheral blood stem cell transplant using 2-chlorodeoxyadenosine (Cladribine; 2-CdA), busulfan, and anti-thymocyte globulin (ATG) for a patient with myelodysplastic syndrome (MDS). He also had hemochromatosis in the liver due to blood transfusions. His post-transplant clinical course was uncomplicated. Non-myeloablative conditioning regimen containing 2-CdA facilitates engraftment with minimal toxicity.

Original languageEnglish (US)
Pages (from-to)88-90
Number of pages3
JournalExperimental Oncology
Volume22
Issue number1-2
StatePublished - Mar 1 2000

Fingerprint

Cladribine
Myelodysplastic Syndromes
Stem Cells
Transplants
Busulfan
Antilymphocyte Serum
Hemochromatosis
Blood Transfusion
Liver

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{33ca0c4bf8594b79bfa7e1d8d012322a,
title = "Non-myeloablative stem cell transplant using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome (MDS)",
abstract = "Non-myeloablative conditioning regimens for allogeneic stem cell transplant have become popular recently. With non-myeloablative conditioning, regimen-related toxicities (RRT) are mild and engraftment of allogeneic graft can be achieved consistently. We performed non-myeloablative allogeneic peripheral blood stem cell transplant using 2-chlorodeoxyadenosine (Cladribine; 2-CdA), busulfan, and anti-thymocyte globulin (ATG) for a patient with myelodysplastic syndrome (MDS). He also had hemochromatosis in the liver due to blood transfusions. His post-transplant clinical course was uncomplicated. Non-myeloablative conditioning regimen containing 2-CdA facilitates engraftment with minimal toxicity.",
author = "T. Saito and S. Seo and R. Tanosaki and Y. Takaue and S. Mineishi",
year = "2000",
month = "3",
day = "1",
language = "English (US)",
volume = "22",
pages = "88--90",
journal = "Experimental Oncology",
issn = "0204-3564",
publisher = "Morion LLC",
number = "1-2",

}

Non-myeloablative stem cell transplant using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome (MDS). / Saito, T.; Seo, S.; Tanosaki, R.; Takaue, Y.; Mineishi, S.

In: Experimental Oncology, Vol. 22, No. 1-2, 01.03.2000, p. 88-90.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Non-myeloablative stem cell transplant using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome (MDS)

AU - Saito, T.

AU - Seo, S.

AU - Tanosaki, R.

AU - Takaue, Y.

AU - Mineishi, S.

PY - 2000/3/1

Y1 - 2000/3/1

N2 - Non-myeloablative conditioning regimens for allogeneic stem cell transplant have become popular recently. With non-myeloablative conditioning, regimen-related toxicities (RRT) are mild and engraftment of allogeneic graft can be achieved consistently. We performed non-myeloablative allogeneic peripheral blood stem cell transplant using 2-chlorodeoxyadenosine (Cladribine; 2-CdA), busulfan, and anti-thymocyte globulin (ATG) for a patient with myelodysplastic syndrome (MDS). He also had hemochromatosis in the liver due to blood transfusions. His post-transplant clinical course was uncomplicated. Non-myeloablative conditioning regimen containing 2-CdA facilitates engraftment with minimal toxicity.

AB - Non-myeloablative conditioning regimens for allogeneic stem cell transplant have become popular recently. With non-myeloablative conditioning, regimen-related toxicities (RRT) are mild and engraftment of allogeneic graft can be achieved consistently. We performed non-myeloablative allogeneic peripheral blood stem cell transplant using 2-chlorodeoxyadenosine (Cladribine; 2-CdA), busulfan, and anti-thymocyte globulin (ATG) for a patient with myelodysplastic syndrome (MDS). He also had hemochromatosis in the liver due to blood transfusions. His post-transplant clinical course was uncomplicated. Non-myeloablative conditioning regimen containing 2-CdA facilitates engraftment with minimal toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0034099908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034099908&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034099908

VL - 22

SP - 88

EP - 90

JO - Experimental Oncology

JF - Experimental Oncology

SN - 0204-3564

IS - 1-2

ER -